Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Myriad Genetics, Inc (NASDAQ: MYGN) closed the day trading at $3.89 down -3.47% from the previous closing price of $4.03. In other words, the price has decreased by -$3.47 from its previous closing price. On the day, 3.86 million shares were traded.
Ratios:
For a better understanding of MYGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.71 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
On May 07, 2025, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight but kept the price unchanged to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 11 ’24 when DIAZ PAUL J sold 15,000 shares for $22.93 per share. The transaction valued at 343,950 led to the insider holds 962,378 shares of the business.
DIAZ PAUL J bought 15,000 shares of MYGN for $343,950 on Oct 11 ’24. On Aug 21 ’24, another insider, Ancona Margaret, who serves as the Officer of the company, bought 11,538 shares for $27.82 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 0.51.
Stock Price History:
Over the past 52 weeks, MYGN has reached a high of $29.30, while it has fallen to a 52-week low of $3.98. The 50-Day Moving Average of the stock is -54.26%, while the 200-Day Moving Average is calculated to be -77.28%.
Shares Statistics:
A total of 92.20M shares are outstanding, with a floating share count of 87.74M. Insiders hold about 4.81% of the company’s shares, while institutions hold 99.04% stake in the company.
